These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29374204)

  • 1. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
    Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation
    Kunz Coyne AJ; Stamper K; El Ghali A; Kebriaei R; Biswas B; Wilson M; Deschenes MV; Tran TT; Arias CA; Rybak MJ
    Microbiol Spectr; 2023 Aug; 11(4):e0034023. PubMed ID: 37338375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.
    DiPippo AJ; Tverdek FP; Tarrand JJ; Munita JM; Tran TT; Arias CA; Shelburne SA; Aitken SL
    J Infect; 2017 Mar; 74(3):243-247. PubMed ID: 27845153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model.
    Wang JT; Yang CJ; Yang JL; Lin SW; Chuang YC; Sheng WH; Chen YC; Chang SC
    Microbiol Spectr; 2022 Oct; 10(5):e0255122. PubMed ID: 36190402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in
    Axell-House DB; Simar SR; Panesso D; Rincon S; Miller WR; Khan A; Pemberton OA; Valdez L; Nguyen AH; Hood KS; Rydell K; DeTranaltes AM; Jones MN; Atterstrom R; Reyes J; Sahasrabhojane PV; Suleyman G; Zervos M; Shelburne SA; Singh KV; Shamoo Y; Hanson BM; Tran TT; Arias CA
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0106923. PubMed ID: 38289081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage and antibiotic combination therapy for recurrent
    Stellfox ME; Fernandes C; Shields RK; Haidar G; Hughes Kramer K; Dembinski E; Mangalea MR; Arya G; Canfield GS; Duerkop BA; Van Tyne D
    mBio; 2024 Mar; 15(3):e0339623. PubMed ID: 38353560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.
    Cairns KA; Udy AA; Peel TN; Abbott IJ; Dooley MJ; Peleg AY
    Clin Microbiol Rev; 2023 Jun; 36(2):e0005922. PubMed ID: 37067406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series.
    Giacobbe DR; Labate L; Tutino S; Baldi F; Russo C; Robba C; Ball L; Dettori S; Marchese A; Dentone C; Magnasco L; Crea F; Willison E; Briano F; Battaglini D; Patroniti N; Brunetti I; Pelosi P; Bassetti M
    Ann Med; 2021 Dec; 53(1):1779-1786. PubMed ID: 34637370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis.
    Eichel VM; Last K; Brühwasser C; von Baum H; Dettenkofer M; Götting T; Grundmann H; Güldenhöven H; Liese J; Martin M; Papan C; Sadaghiani C; Wendt C; Werner G; Mutters NT
    J Hosp Infect; 2023 Nov; 141():119-128. PubMed ID: 37734679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible
    Bager P; Kähler J; Andersson M; Holzknecht BJ; Kjær Hansen SG; Schønning K; Nielsen KL; Koch K; Pinholt M; Voldstedlund M; Larsen AR; Kristensen B; Mølbak K; Sönksen UW; Skovgaard S; Skov R; Hammerum AM
    Emerg Microbes Infect; 2024 Dec; 13(1):2309969. PubMed ID: 38258968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.
    Kelesidis T; Humphries R; Uslan DZ; Pegues DA
    Clin Infect Dis; 2011 Jan; 52(2):228-34. PubMed ID: 21288849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: A systematic review and meta-analysis.
    Umemura T; Kato H; Asai N; Hagihara M; Hirai J; Yamagishi Y; Mikamo H
    Heliyon; 2024 Apr; 10(8):e29811. PubMed ID: 38681574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.
    Butler AM; Olsen MA; Merz LR; Guth RM; Woeltje KF; Camins BC; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):28-35. PubMed ID: 19951200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and microbiological characteristics of vancomycin-resistant Enterococcus faecium bloodstream infection in Central Taiwan.
    Chen CH; Lin LC; Chang YJ; Chang CY
    Medicine (Baltimore); 2017 Dec; 96(49):e9000. PubMed ID: 29245276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcomes associated with enterococcal blood stream infection among liver and kidney transplant recipients.
    He KD; Naqvi SS; Cowan VL; Stack CM; Alonso CD; Blair BM
    Clin Transplant; 2024 Mar; 38(3):e15285. PubMed ID: 38516923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis.
    Alosaimy S; Sabagha NL; Lagnf AM; Zasowski EJ; Morrisette T; Jorgensen SCJ; Trinh TD; Mynatt RP; Rybak MJ
    Infect Dis Ther; 2020 Jun; 9(2):325-339. PubMed ID: 32248513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogen.
    Morley VJ; Kinnear CL; Sim DG; Olson SN; Jackson LM; Hansen E; Usher GA; Showalter SA; Pai MP; Woods RJ; Read AF
    Elife; 2020 Dec; 9():. PubMed ID: 33258450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections.
    Zerbato V; Pol R; Sanson G; Suru DA; Pin E; Tabolli V; Monticelli J; Busetti M; Toc DA; Crocè LS; Luzzati R; Di Bella S
    Antibiotics (Basel); 2024 Jun; 13(7):. PubMed ID: 39061283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-Infusion β-Lactam Therapy, Mortality, and Subsequent Antibiotic Resistance Among Hospitalized Adults With Gram-Negative Bloodstream Infections.
    Karaba SM; Cosgrove SE; Lee JH; Fiawoo S; Heil EL; Quartuccio KS; Shihadeh KC; Tamma PD
    JAMA Netw Open; 2024 Jul; 7(7):e2418234. PubMed ID: 38954416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid versus daptomycin treatment for periprosthetic joint infections: a retrospective cohort study.
    Sawada M; Oe K; Hirata M; Kawamura H; Ueda N; Nakamura T; Iida H; Saito T
    J Orthop Surg Res; 2019 Oct; 14(1):334. PubMed ID: 31651331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.